Age seven years
|
Hospitalised group
|
Not hospitalised group
| |
---|
FVC (liters)
|
RS- (n = 22)
|
RS+ (n = 35)
|
95% CIe
|
Both (n = 57)
|
Ctr (n = 64)
|
95% CIe
|
---|
Predicteda
|
1.78
|
1.76
|
-0.12 0.15
|
1.77
|
1.82
|
-0.04 0.14
|
Before salbutamol
|
1.65
|
1.65
|
-0.17 0.17
|
1.65
|
1.75
|
-0.02 0.19
|
After salbutamolc
|
1.69
|
1.69
|
-0.16 0.17
|
1.69
|
1.81
|
0.004 0.22
|
Reversibilityb
|
2.5
|
1.9
|
-2.3 3.6
|
2.1
|
3.3
|
-9.3 3.2
|
FEV
1
(liters)
|
Predicteda
|
1.51
|
1.50
|
-0.10 0.12
|
1.51
|
1.54
|
-0.04 0.11
|
Before salbutamolc
|
1.50
|
1.51
|
-0.16 0.13
|
1.50
|
1.64
|
0.05 0.23
|
After salbutamol
|
1.57
|
1.59
|
-0.16 0.11
|
1.59
|
1.70
|
0.03 0.20
|
Reversibilityb
|
4.9
|
5.6
|
-4.0 2.6
|
5.3
|
5.6
|
-3.5 3.9
|
FEF
50
(liters/min)
|
Predicteda
|
2.34
|
2.33
|
-0.12 0.14
|
2.33
|
2.36
|
-0.07 0.13
|
Before salbutamold
|
1.92
|
1.99
|
-0.35 0.20
|
1.96
|
2.28
|
0.15 0.49
|
After salbutamold
|
2.17
|
2.34
|
-0.43 0.10
|
2.28
|
2.56
|
0.11 0.46
|
Reversibilityb
|
11.7
|
14.5
|
-10.0 4.3
|
13.4
|
9.6
|
-9.2 1.6
|
-
a According to European Respiratory Society 1993 Update
-
b Percent improvement 10 minutes after inhalation of 0.2 mg salbutamol
-
c P < 0.05 with independent samples T-test between the hospitalised group and not hospitalised group
-
d P < 0.01 with independent samples T-test between the hospitalised group and not hospitalised group
-
e 95% confidence interval (CI) of difference between means